Indaptus secures $6 million investment, appoints new co-CEO Dec 29, 2025 07:00AM
Indaptus Therapeutics (INDP) Misses Q3 EPS by 298c Nov 12, 2025 04:53PM
Indaptus reports mixed results from Decoy20 cancer therapy trial Sep 4, 2025 04:02PM
Indaptus Therapeutics, Inc. (INDP) Misses Q2 EPS by 890c Aug 13, 2025 06:45PM
Indaptus Therapeutics (INDP) Files for 2.16M Share Offering by Selling Stockholders Aug 13, 2025 04:24PM


Aug 13, 2025 04:18PM Indaptus Therapeutics (INDP) Files $100M Mixed Shelf
Jul 1, 2025 08:14AM Indaptus Therapeutics (INDP) Announces Additional Sale of $3.4M in Private Placement of Convertible Notes and Warrants
Jun 25, 2025 07:00AM Indaptus Therapeutics (INDP) Announces Reverse Share Split
Jun 13, 2025 08:00AM Indaptus Therapeutics (INDP) Announces Sale of $2.3 Million in Private Placement of Convertible Notes and Warrants
May 14, 2025 05:13PM Indaptus Therapeutics, Inc. (INDP) Misses Q1 EPS by 14c
Mar 20, 2025 08:01AM Indaptus Therapeutics (INDP) Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
Mar 18, 2025 08:05AM Indaptus Therapeutics (INDP) Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
Mar 4, 2025 08:00AM Indaptus Therapeutics (INDP) expands Patent Portfolio in China, Japan, and Israel
Feb 5, 2025 04:19PM Indaptus Therapeutics (INDP) Files for 4.37M Share Offering by Selling Stockholders
Feb 5, 2025 08:01AM Indaptus Therapeutics (INDP) Receives Approval from Health Canada to Expand Clinical Trial of Decoy20
Jan 8, 2025 08:02AM Indaptus Therapeutics (INDP) Provides Year-End Review and Outlook for 2025
Dec 23, 2024 04:58PM Indaptus Therapeutics (INDP) Files for 1.94M Share Offering by Selling Stockholders
Nov 22, 2024 08:37AM Indaptus Therapeutics (INDP) Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement
Nov 12, 2024 05:34PM Indaptus Therapeutics, Inc. (INDP) Tops Q3 EPS by 16c
Nov 7, 2024 08:02AM Indaptus Therapeutics (INDP) Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20
Oct 22, 2024 08:01AM Indaptus Therapeutics (INDP) Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
Oct 16, 2024 06:56AM H.C. Wainwright Reiterates Buy Rating on Indaptus Therapeutics (INDP)
Aug 12, 2024 09:49AM Indaptus Therapeutics, Inc. (INDP) Tops Q2 EPS by 11c
Aug 7, 2024 07:00AM Indaptus Therapeutics (INDP) Announces 1.64M Share Offering at $1.825/sh